Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death

Cancer Chemotherapy and Pharmacology

Volumn 75, Issue 1, 2015, Pages 1-15

  Singh, Simendra ^a  

^a SHARDA UNIVERSITY   (India)

Author keywords

Apoptosis; Detoxification; Glutathione S transferase; Polymorphism; Signaling

Indexed keywords

7 NITRO 2,1,3, BENZOXADIAZOLE DERIVATIVE; ALOE EMODIN; ANTINEOPLASTIC AGENT; ARTEMISININ; BENASTATIN A; BUSULFAN; CANFOSFAMIDE; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETACRYNIC ACID; ETOPOSIDE; EZATIOSTAT; GLUTATHIONE DERIVATIVE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; HALOENOL LACTONE; MELPHALAN; NITAZOXANIDE; NITRIC OXIDE DONOR; PACLITAXEL; PYRIMETHAMINE; QUINIDINE; QUININE; TETRACYCLINE; THIOTEPA; UNCLASSIFIED DRUG; GSTP1 PROTEIN, HUMAN; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CELL PROLIFERATION; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER THERAPY; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; DETOXIFICATION; DRUG RESISTANCE; ENZYME PHOSPHORYLATION; ENZYME POLYMORPHISM; ENZYME STRUCTURE; GENOTYPE; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; TISSUE DISTRIBUTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG DETOXIFICATION; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; METABOLIC DETOXICATION, PHASE II; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84925231779     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-014-2566-x     Document Type: Review

References (128)

1. Tew KD, Townsend D.M. (2012) Glutathione S-transferases as determinants of cell survival and death. Antioxid Redox Signal 17:1728-1737
2. Board PG, Menon D. (2013) Glutathione transferases, regulators of cellular metabolism and physiology. Biochim Biophys Acta 1830:3267-3288
3. Hebert H, Jegerschöld C (2007) The structure of membrane associated proteins in eicosanoid and glutathione metabolism as determined by electron crystallography. Curr Opin Struct Biol 17:396-404
4. Hayes JD, Flanagan JU, Jowsey I.R. (2005) Glutathione trans-ferases. Ann Rev Pharmacol Toxicol 45:51-88
5. Deponte M (2013) Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochim Biophys Acta 1830:3217-3266
6. Wu B, Dong D. (2012) Human cytosolic glutathione trans-ferases: structure, function, and drug discovery. Trends Pharmacol Sci 33:656-668
7. Dourado DF, Fernandes PA, Pedro A, Ramos M.J. (2008) Mammalian cytosolic glutathione transferases. Curr Prot Pept Sci 9:325-337
8. Oakley A (2011) Glutathione transferases: a structural perspective. Drug Metab Rev 43:138-151
9. Dourado DF, Fernandes PA, Mannervik B, Ramos M.J. (2008) Glutathione transferase: new model for glutathione activation. Chemistry 14:9591-9598
10. Henderson AP, Bleasdale C, Delaney K., Lindstrom AB, Rappaport SM, Waidyanatha S, Watson W.P., Golding B.T. (2005) Evidence for the formation of Michael adducts from reactions of (E, E)-muconaldehyde with glutathione and other thiols. Bioorg Chem 33:363-373
11. Di Pietro G., Magno LA, Rios-Santos F (2010) Glutathione S-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol 6:153-170
12. Raijmakers MT, Steegers EA, Peters W.H. (2001) Glutathione S-transferases and thiol concentrations in embryonic and early fetal tissues. Hum Reprod 16:2445-2450
13. Sherratt PJ, Hayes J.D. (2001) Glutathione S-transferases. In: Ioannides C (ed) Enzyme systems that metabolise drugs and other xenobiotics. Wiley, UK, pp 319-352
14. Rowe JD, Nieves E, Listowsky I. (1997) Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem J 325:481-486
15. Coles BF, Chen G, Kadlubar F.F., Radominska-Pandya A (2002) Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals. Arch Biochem Biophys 403:270-276
16. Schnekenburger M, Morceau F, Henry E., Blasius R, Dicato M, Trentesaux C., Diederich M. (2006) Transcriptional and post-transcriptional regulation of glutathione S-transferase P1 expression during butyric acid-induced differentiation of K562 cells. Leuk Res 30:561-568
17. Oguztuzun S, Abu-Hijleh A, Coban T., Bulbul D, Kilic M, Iscan M. (2011) GST isoenzymes in matched normal and neoplastic breast tissue. Neoplasma 58:304-310
18. Bostwick DG, Meiers I, Shanks J.H. (2007) Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. Hum Pathol 38:1394-1401
19. Townsend D, Tew K. (2003) Cancer drugs, genetic variation and the glutathione S-transferase gene family. Am J Pharmacogenomics 3:157-172
20. Peklak-Scott C., Smitherman PK, Townsend A.J., Morrow C.S. (2008) Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin. Mol Cancer Ther 7:3247-3255
21. Kraggerud SM, Oldenburg J, Alnaes G.I., Berg M., Kristensen VN, Fossa SD, Lothe R.A. (2009) Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology. Pharmacogenet Genomics 19:751-759
22. Xie P, Liang Y, Liang G., Liu B. (2014) Association between GSTP1 Ile105Val polymorphism and glioma risk: a systematic review and meta-analysis. Tumour Biol 35: 493-499
23. Yao L, Ji G, Gu A., Zhao P, Liu N. (2012) An updated pooled analysis of glutathione S-transferase genotype polymorphisms and risk of adult gliomas. Asian Pac J Cancer Prev 13:157-163
24. Huang G, Mills L, Worth L.L. (2007) Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells. Mol Cancer Ther 6:1610-1619
25. Lovrić E, Gatalica Z, Eyzaguirre E, Kruslin B (2010) Expression of maspin and glutathionine S-transferase-pi in normal human prostate andprostatic carcinomas. Appl Immunohistochem Mol Morphol 18:429-432
26. Economopoulos KP, Sergentanis T.N. (2010) GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer 46:1617-1631
27. Ahn J, Gammon MD, Santella R.M., Gaudet MM, Britton JA, Teitelbaum SL, Terry M.B., Neugut AI, Eng SM, Zhang Y, Garza C., Ambrosone C.B. (2006) Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 27:1876-1882
28. van Nguyen T., Janssen MJ, van Oijen MGH, Bergevoet SM, te Morsche RHM, van Asten HAGH, Laheij RJF, Peters WHM, Jansen JBMJ (2010) Genetic polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and gastric cancer risk in a Vietnamese population. Oncology Res 18:349-355
29. Maekawa K, Hamaguchi T, Saito Y., Tatewaki N, Kurose K, Kaniwa N., Eguchi Nakajima T, Kato K, Yamada Y., Shimada Y, Yoshida T, Kamatani N, Ura T, Saito M, Muro K, Fuse N, Yoshino T, Doi T, Otsu A, Saijo N, Sawada J, Okuda H, Matsumura Y (2011) Genetic variation and haplotype structures of the glutathione S-transferase genes GSTA1 and GSTA2 in Japanese colorectal cancer patients. Drug Metab Pharmacokinet 26:646-658
30. Martinez V, Kennedy S, Doolan P., Gammell P, Joyce H, Kenny E., Prakash Mehta J, Ryan E, O'Connor R, Crown J, Clynes M, O'Driscoll L (2008) Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue. Breast Cancer Res Treat 110:521-530
31. Carlsten C, Sagoo GS, Frodsham A.J., Burke W., Higgins J.P. (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167:759-774
32. Zhou Y, Zhuang W, Yin Y.Q., Liu GJ, Wu TX, Yao X, Du L., Wei ML, Wu XT, Wang H. (2010) Glutathione S-transferase M1 null genotype associated with gastric cancer among Asians. Dig Dis Sci 55:1824-1830
33. Gao L-B, Pan X-M, Li L-J, Liang W-B, Bai P, Rao L, Su X-W, Wang T, Zhou B, Wei Y-G, Zhang L (2011) Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis. PLoS ONE 6:e20157
34. Weiss JR, Kopecky KJ, Godwin J, Anderson J., Willman CL, Moysich KB, Slovak ML, Hoque A, Ambrosone C.B. (2006) Glutathione S-transferase (GSTM1, GSTT1 and GSTA1) polymorphisms and outcomes after treatment for acute myeloid leukemia: pharmacogenetics in Southwest Oncology Group (SWOG) clinical trials. Leukemia 20:2169-2171
35. Xu Y, Wang J, Dong W. (2014) GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis. PLoS ONE 9:e83851
36. Fryer AA, Ramsay HM, Lovatt T.J., Jones PW, Hawley CM, Nicol DL, Strange R.C., Harden P.N. (2005) Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients. Carcinogenesis 26:185-191
37. Zhang Y, Ni Y, Zhang H., Pan Y, Ma J, Wang L. (2012) Association between GSTM1 and GSTT1 allelic variants and head and neck squamous cell carcinoma. PLoS ONE 7:e47579
38. Anantharaman D, Chaubal PM, Kannan S, Bhisey R.A., Mahimkar M.B. (2007) Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 28:1455-1462
39. de Aguiar E.S., Giacomazzi J, Schmidt A.V., Bock H., Saraiva-Pereira ML, Schuler-Faccini L, Duarte Filho D, dos Santos PA, Giugliani R, Caleffi M, Camey SA, Ashton-Prolla P (2012) GSTM1, GSTT1, and GSTP1 polymorphisms, breast cancer risk factors and mammographic density in women submitted to breast cancer screening. Rev Bras Epidemiol 15:246-255
40. Settheetham-Ishida W., Yuenyao P, Kularbkaew C., Settheetham D, Ishida T. (2009) Glutathione S-transferase (GSTM1 and GSTT1) polymorphisms in cervical cancer in Northeastern Thailand. Asian Pac J Can Prev 10:365-368
41. Howells RE, Redman CW, Dhar K.K., Sarhanis P., Musgrove C, Jones PW, Alldersea J, Fryer A.A., Hoban PR, Strange R.C. (1998) Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer. Clin Cancer Res 4:2439-2445
42. Özten N, Sunguroʇlu A, Bosland M.C. (2012) Variations in glutathione S-transferase genes influence risk of chronic myeloid leukemia. Hematol Oncol 30:150-155
43. Dunna NR, Vure S, Sailaja K., Surekha D, Raghunadharao D, Rajappa S., Vishnupriya S. (2013) Deletion of GSTM1 and T1 genes as a risk factor for development of acute leukemia. Asian Pac J Cancer Prev 14:2221-2224
44. Nagle CM, Chenevix-Trench G, Spurdle A.B., Webb P.M. (2007) The role of glutathione S-transferase polymorphisms in ovarian cancer survival. Eur J Cancer 43:283-290
45. Goekkurt E, Hoehn S, Wolschke C., Wittmer C, Stueber C, Hossfeld D.K., Stoehlmacher J. (2006) Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)novel predictors for response and survival in gastric cancer patients. Br J Cancer 94:281-286
46. Ge J, Tian AX, Wang Q.S., Kong PZ, Yu Y, Li XQ, Cao X.C., Feng Y.M. (2013) The GSTP1 105Val allele increases breast cancer risk and aggressiveness but enhances response to cyclophosphamide chemotherapy in North China. PLoS ONE 8:e67589
47. Voso MT, Hohaus S, Guidi F., Fabiani E, D'Alò F, Groner S, Späth D, Doehner K, Leone G, Doehner H, Schlenk RF (2008) Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. Leukemia 22:1685-1691
48. Lo HW, Ali-Osman F (2007) Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr Opin Pharmacol 7:367-374
49. Li J, Bluth M.H. (2011) Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy. Pharmacogenom Personal Med 4:11-33
50. Sau A, Pellizzari Tregno F, Valentino F, Federici G., Caccuri A.M. (2010) Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys 500:116-122
51. Ahire S, Kothawade V, Singh S. (2012) A review of glutathione S-transferase in drug resistance. Int J Univ Pharm Life Sci 2
52. Zeng D-F, Zhang J., Zhu L-D, Kong P-Y, Li J-P, Zhang X, Xu W, Wang J-I, Pen X-G, Wang P, Liu S-H (2014) Analysis of drug resistance-associated proteins expressions of patients with the recurrent of acute leukemia via protein microarray technology. Eur Rev Med Pharmacol Sci 18:537-543
53. Kolwijck E, Zusterzeel PLM, Roelofs HMJ, Hendriks JC, Peters WHM, Massuger LFAG (2009) GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer. Cancer Epidemiol Biomarkers Prev 18:2176-2181
54. Tew KD, Monks A, Barone L., Rosser D, Akerman G, Montali J.A., Wheatley JB, Schmidt DE Jr (1996) Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Mol Pharm 50:149-159
55. Suk K (2012) Proteomic analysis of glioma chemoresistance. Kyoungho Suk. Curr Neuropharmacol 10:72-79
56. Haas S, Pierl C, Harth V., Pesch B, Rabstein S, Brüning T, Ko Y., Hamann U, Justenhoven C, Brauch H., Fischer H.P. (2006) Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas. Int J Cancer 119:1785-1791
57. Grimminger PP, Maus MK, Schneider P.M., Metzger R., Hölscher AH, Sugita H., Danenberg PV, Alakus H, Brabender J. (2012) Glutathione S-transferase P1 (GST-P1) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC. Lung Cancer 78:87-91
58. Tan KL, Jankova L, Chan C., Fung CL, Clarke C, Lin BP, Robertson G, Molloy M., Chapuis PH, Bokey L, Dent OF, Clarke S.J. (2011) Clinicopathological correlates and prognostic significance of glutathione S-transferase Pi expression in 468 patients after potentially curative resection of node-positive colonic cancer. Histopathology 59:1057-1070
59. Simic T, Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, Mimic-Oka J (2009) Glutathione S-transferases in kidney and urinary bladder tumors. Nat Rev Urol 6:281-289
60. Soh Y, Goto S, Kitajima M., Moriyama S, Kotera K, Nakayama T., Nakajima H, Kondo T, Ishimaru T. (2005) Nuclear localisation of glutathione S-transferase pi is an evaluation factor for drug resistance in gynaecological cancers. Clin Oncol (R Coll Radiol) 17:264-270
61. Huang JX, Li FY, Xiao W, Song Z.X., Qian RY, Chen P, Salminen E. (2009) Expression of thymidylate synthase d glutathione S-transferase pi in patients with esophageal squamous cell carcinoma. World J Gastroenterol 15:4316-4321
62. Geng M, Wang L, Chen X., Cao R, Li P. (2013) The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer. Diagn Pathal 8:198
63. Finn NA, Findley HW, Kemp M.L. (2011) A switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicity. PLoS Comput Biol 7:e1002151
64. Kanwal R, Pandey M, Bhaskaran N., Maclennan GT, Fu P, Ponsky LE, Gupta S. (2014) Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1. Mol Carcinog 53:8-18
65. Brognard J, Hunter T. (2011) Protein kinase signaling networks in cancer. Curr Opin Genet Dev 21:4-11
66. Ebelt ND, Cantrell MA, van den Berg CL (2013) c-Jun N-terminal kinases mediate a wide range of targets in the metastatic cascade. Genes Cancer 4:378-387
67. Tournier C (2013) The 2 faces of JNK signaling in cancer. Genes Cancer 4:397-400
68. Adler V, Yin Z, Fuchs S.Y., Benerza M., Rosario L, Tew KD, Pincus M.R., Sardana M., Henderson CJ, Wolf CR, Davis RJ, Ronai Z. (1999) Regulation of JNK signaling by GSTp. EMBO J 18:1321-1334
69. 2-induced cell death via coordinated regulation of stress kinases. Cancer Res 60:4053-4057
70. Bernardini S, Bellincampi L, Ballerini S., Ranalli M, Pastrol A, Cortese C., Federici G. (2002) Role of GST P1-1 in mediating the effect of etoposide on human neuroblastoma cell line ShSy5y. J Cell Biochem 86:340-347
71. Chen N, She Q, Bode A.M., Dong Z. (2002) Differential gene expression profiles of Jnk1- and Jnk2-deficient murine fibro-blast cells. Cancer Res 62:1300-1304
72. Bubici C, Papa S. (2014) JNK signalling in cancer: in need of new, smarter therapeutic targets. Br J Pharmacol 171:24-37
73. Sau A, Filomeni G, Pezzola S., D'Aguanno S, Tregno FP, Urbani A, Serra M., Pasello M, Picci P, Federici G., Caccuri A.M. (2012) Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and - resistant human osteosarcoma cell lines. Mol BioSyst 8:994-1006
74. Yang Y, Chang J-Z, Singhal SS, Saini M, Pandaya U., Awasthi S, Awasthi Y.C. (2001) Role of glutathione S-transferases in protection against lipid peroxidation. Overexpression of hGSTA2-2 in K562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation. J Biol Chem 276:19220-19230
75. Cheng J-Z, Singhal S.S., Sharma A., Saini M, Yang Y, Awasthi S., Zimniak P, Awasthi Y.C. (2001) Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal-induced apoptosis by inhibiting JNK-mediated signaling. Arch Biochem Biophys 392:197-207
76. Romero L, Andrews K, Lorraine N.G., O'Rourke K, Maslem A, Kirby G. (2006) Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. Biochem J 400:135-141
77. Shiizaki S, Naguro I, Ichijo H. (2013) Activation mechanisms of ASK1 in response to various stresses and its significance in intracellular signaling Adv Biol Regul 53:135-144
78. Cho SG, Lee YH, Park H.S., Ryoo K., Kang KW, Park J, Eom SJ, Kim M.J., Chang TS, Choi SY, Shim J, Kim Y., Dong MS, Lee MJ, Kim SG, Ichijo H, Choi EJ (2001) Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem 276:12749-12755
79. Dorion S, Lambert H, Landry J. (2002) Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J Biol Chem 34:30792-30797
80. Wu Y, Fan Y, Xue B., Luo L, Shen J, Zhang S., Jiang Y, Yin Z. (2006) Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25:5787-5800
81. Lo H-W, Antoun G.R., Ali-Osman F (2004) The human glutathione S-transferase P1 protein is phosphorylated and its metabolic function enhanced by the Ser/Thr protein kinases, cAMPdependent protein kinase and protein kinase C, in glioblastoma cells. Cancer Res 64:9131-9138
82. Okamura T, Singh S, Buolamwini J., Haystead T, Friedman H, Bigner D., Ali-Osman F (2009) Tyrosine phosphorylation of the human glutathione S-transferase P1 by epidermal growth factor receptor. J Biol Chem 284:16979-16989
83. Singh S, Okamura T, Ali-Osman F (2009) Serine phosphorylation of glutathione S-transferase P1 (GSTP1) by PKCα enhances GSTP1-dependent cisplatin metabolism and resistance in human glioma cells. Biochem Pharmacol 80:1343-1355
84. Pagano G, Youssoufian H. (2003) Fanconi anaemia proteins: major roles in cell protection against oxidative damage. BioEssays 25:589-595
85. Cumming RC, Lightfoot J, Beard K., Youssoufian H, O'Brien PJ, Buchwald M. (2001) Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med 7:814-820
86. Koh J, Ali-Osman F (2007) GSTP1 forms a stable, non-covalent complex with the tissue transglutaminase TGM2 in human glioblastoma cells. Proc Annu Meet Am Assoc Cancer Res 98:4488
87. Kamran MZ, Patil P, Gude R.P. (2013) Role of STAT3 in cancer metastasis and translational advances. Biomed Res Int 421821
88. Wang Y, van Boxel-Dezaire AH, Cheon H, Yang J, Stark GR (2013) STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor. Proc Natl Acad Sci USA 110:16975-16980
89. Kou X, Chen N, Feng Z., Luo L, Yin Z. (2013) GSTP1 negatively regulates Stat3 activation in epidermal growth factor signaling. Oncol Lett 5:1053-1057
90. Pastore A, Piemonte F. (2012) S-Glutathionylation signaling in cell biology: progress and prospects. Eur J Pharm Sci 46:279-292
91. Townsend DM, Manevich Y, He L., Hutchens S, Pazoles CJ, Tew K.D. (2009) Novel role for glutathione S-transferase pi. Regulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 284:436-445
92. Nevalainen TJ (2010) 1-Cysteine peroxiredoxin: a dual-function enzyme with peroxidase and acidic Ca2 + -independent phospholipase A2 activities. Biochimie 92:638-644
93. Neumann CA, Cao J, Manevich Y. (2009) Peroxiredoxin 1 and its role in cell signaling. Cell Cycle 8:4072-4078
94. Ralat LA, Misquitta SA, Manevich Y, Fisher A.B., Colman R.F. (2008) Characterization of the complex of glutathione S-trans-ferase pi and 1-cysteine peroxiredoxin. Arch Biochem Biophys 474:109-118
95. Manevich Y, Feinstein SI, Fisher A.B. (2004) Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with πGST. Proc Natl Acad Sci USA 101:3780-3785
96. Xu W, Liu LZ, Loizidou M, Ahmed M., Charles I.G. (2002) The role of nitric oxide in cancer. Cell Res 12:311-320
97. Richardson DR, Lok H.C. (2008) The nitric oxide-iron interplay in mammalian cells: transport and storage of dinitrosyl iron complexes. Biochim Biophys Acta 1780:638-651
98. Singh S, Gupta A.K. (2011) Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies. Cancer Chemother Pharmacol 67:1211-1224
99. Pedersen JZ, De Maria F, Turella P, Federici G., Mattei M, Fabrini R, Dawood K.F., Massimi M., Caccuri AM, Ricci G (2007) Glutathione transferases sequester toxic dinitrosyl-iron complexes in cells: a protection mechanism against excess nitric oxide. J Biol Chem 282:6364-6371
100. Lok HC, Suryo Rahmanto Y, Hawkins CL, Kalinowski D.S., Morrow CS, Townsend AJ, Ponka P, Richardson D.R. (2012) Nitric oxide storage and transport in cells are mediated by glutathione S-transferase P1-1 and multidrug resistance protein 1 via dinitrosyl iron complexes. J Biol Chem 287:607-618
101. van Iersel M.L., Ploemen JP, Lo Bello M, Federici G, van Bladeren PJ (1997) Interactions of alpha, beta-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1. Chem Biol Interact 108:67-78
102. Tirona RG, Pang K.S. (1999) Bimolecular glutathione conjugation kinetics of ethacrynic acid in rat liver: in vitro and perfusion studies. J Pharmacol Exp Ther 290:1230-1241
103. Morgan AS, Ciaccio PJ, Tew K.D., Kauvar L.M. (1996) Isozymespecific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother Pharmacol 37:363-370
104. Johansson K, Ito M, Schophuizen C.M., Mathew Thengumtharayil S, Heuser VD, Zhang J, Shimoji M., Vahter M, Ang WH, Dyson P.J., Shibata A., Shuto S, Ito Y, Abe H, Morgenstern R (2011) Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance. Mol Pharm 8:1698-1708
105. Rodriguez-Vicente J., Vicente-Ortega V, Canteras-Jordana M (1998) The effects of different antineoplastic agents and of pretreatment by modulators on three melanoma lines. Cancer 82:495-502
106. Zhang P, Chen JH, Dong X, Tang M.T., Gao LY, Zhao GS, Yu LG, Guo X.L. (2013) 6r, a novel oxadiazole analogue of ethacrynic acid, exhibits antitumor activity both in vitro and in vivo by induction of cell apoptosis and S-phase arrest. Biomed Pharmacother 67:58-65
107. O'Dwyer P.J., LaCreta F, Nash S., Tinsley PW, Schilder R, Clapper ML, Tew K.D., Panting L., Litwin S, Comis R.L. (1991) Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res 51:6059-6065
108. Hamilton D, Batist G. (2005) TLK-199 (Telik). IDrugs 8:662-669
109. O'Brien M.L., Vulevic B, Freer S., Boyd J, Shen H, Tew K.D. (1999) Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein. J Pharmacol Exp Ther 291:1348-1355
110. Raza A, Galili N, Callander N., Ochoa L, Piro L, Emanuel P., Williams S, Burris H, Faderl S., Estrov Z, Curtin P, Larson RA, Keck JG, Jones M, Meng L, Brown GL (2009) Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome. J Hematol Oncol 2:20
111. Ruscoe JE, Rosario LA, Wang T, Gaté L, Arifoglu P, Wolf CR, Henderson CJ, Ronai Z, Tew KD (2001) Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 298:339-345
112. Tew KD (2005) TLK-286: a novel glutathione S-transferase-activated prodrug. Expert Opin Investig Drugs 14:1047-1054
113. Dourado DFAR, Fernandes PA, Ramos M.J., Mannervik B. (2013) Mechanism of glutathione transferase P1-1-catalyzed activation of the prodrug canfosfamide (TLK286, TELCYTA). Biochemistry 52:8069-8078
114. Xu H, Namgoong S-Y, Roth E, Brown G.L., Keck J.G. (2004) Synergistic effect of TELCYTA™ (TLK286) in combination with paclitaxel, doxorubicin, carboplatin, oxaliplatin, cisplatin, docetaxel, gemcitabine and iressa in human cancer cells. Proc Amer Assoc Cancer Res 45, Abstract #2008
115. Izbicka E, Lawrence R, Cerna C., Von Hoff DD, Sanderson P.E. (1997) Activity of TER286 against human tumor colony-forming units. Anticancer Drugs 8:345-348
116. Morgan AS, Sanderson PE, Borch R.F., Tew KD, Niitsu Y, Takayama T, Von Hoff DD, Izbicka E, Mangold G, Paul C., Broberg U, Mannervik B, Henner WD, Kauvar LM (1998) Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase. Cancer Res 58:2568-2575
117. Rosen LS, Brown J, Laxa B., Boulos L, Reiswig L, Henner W.D., Lum RT, Schow SR, Maack CA, Keck J.G., Mascavage JC, Dombroski JA, Gomez RF, Brown GL (2003) Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies. Clin Cancer Res 9:1628-1638
118. Carboplatin, Paclitaxel and TLK286 (Telcyta) as first-line therapy in advanced non-small cell lung cancer. http://www.cancer.gov/clinicaltrials (Protocol ID: TLK286.2023 NCT00088556) Oct 2013
119. Liu J, Li C, Qu W., Leslie E, Bonifant CL, Buzard G.S., Saavedra JE, Keefer LK, Waalkes M.P. (2004) Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation. Mol Cancer Ther 3:709-714
120. Saavedra JE, Srinivasan A, Buzard G.S., Davies KM, Waterhouse DJ, Inami K, Wilde T.C., Citro ML, Cuellar M, Deschamps JR, Parrish D, Shami P.J., Findlay VJ, Townsend DM, Tew KD, Singh S, Jia L, Ji X, Keefer LK (2006) PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity. J Med Chem 49:1157-1164
121. Findlay VJ, Townsend DM, Saavedra J.E., Buzard GS, Citro ML, Keefer LK, Ji X, Tew K.D. (2004) Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. Mol Pharmacol 65:1070-1079
122. Ricci G, De Maria F, Antonini G, Turella P., Bullo A, Stella L, Filomeni G., Federici G, Caccuri AM (2005) 7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-transferases. Mechanism of action of potential anticancer drugs. J Biol Chem 280:26397-26405
123. Mahajan S, Atkins W.M. (2005) The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases. Cell Mol Life Sci 62:1221-1233
124. Müller J., Sidler D, Nachbur U., Wastling J, Brunner T, Hemphill A. (2008) Thiazolides inhibit growth and induce glutathione S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells. Int J Cancer 123:1797-1806
125. Zheng J, Liu G, Tozkoparan B., Wen D. (2005) Mechanistic studies of inactivation of glutathione S-transferase Pi isozyme by a haloenol lactone derivative. Med Chem 1:191-198
126. Mukanganyama S, Widersten M, Naik Y.S., Mannervik B., Hasler J.A. (2002) Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance. Int J Cancer 97:700-705
127. Lu GD, Shen HM, Chung M.C., Ong C.N. (2007) Critical role of oxidative stress and sustained JNK activation in aloe-emodinmediated apoptotic cell death in human hepatoma cells. Carcinogenesis 28:1937-1945
128. Aoyama T, Kojima F, Yamazaki T., Tatee T, Abe F, Muraoka Y., Naganawa H, Aoyagi T, Takeuchi T. (1993) Benastatins C and D, new inhibitors of glutathione S-transferase, produced by Streptomyces sp. MI384-DF12. Production, isolation, structure determination and biological activities. J Antibiot (Tokyo) 46:712-718